Showing 104,721 - 104,729 results of 104,729 for search '(( 3 point decrease ) OR ( 5 ((((wt decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.26s Refine Results
  1. 104721

    Mode of virus transmission differentially steers susceptibility to entry inhibition. by Irene A. Abela (173068)

    Published 2012
    “…Red and black values denote IC50 (nM) of during cell-cell and cell-free transmission, respectively. Data points represent means of duplicates from three independent inhibition experiments. …”
  2. 104722

    Table_1_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.docx by Zhiyong Zhu (2559349)

    Published 2023
    “…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
  3. 104723

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  4. 104724

    Table_2_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.DOCX by Zhiyong Zhu (2559349)

    Published 2023
    “…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
  5. 104725

    Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  6. 104726

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  7. 104727

    Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  8. 104728

    Design of an inducible CRISPRi gene-silencing system for <i>S</i>. <i>mutans</i>. by Robert C. Shields (8551326)

    Published 2020
    “…As the xylose concentration was decreased, data points change from a dark to a light blue color. …”
  9. 104729

    Interaction between tombusvirus replication proteins and Pdc1 fermentation enzyme. by Wenwu Lin (7542863)

    Published 2019
    “…Each experiment was repeated three times.</p>…”